BSE filing, NSE: HBLENGINE. Summary written from the filing by ALFA Finder's alert engine.
HBL Engineering Ltd: key numbers
- Share price
- ₹810.00
- Market cap
- ₹22,453 Cr
- Revenue (annual)
- ₹3,303 Cr
- Net profit (annual)
- ₹814.9 Cr
- P/E (TTM)
- 28.8×Sector 41.7×
- Promoter holding
- 59.11%+0.00% QoQ
- FII holding
- 5.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from HBL Engineering Ltd
All →HBL Engineering Board Meeting Date
HBL Engineering has intimated a board meeting scheduled for 7 November 2026 to consider unaudited half-yearly financial results. No results or figures are disclosed in this advance notice.
HBL Engineering Credit Rating
CARE Ratings upgraded HBL Engineering's long-term bank facilities to 'CARE AA-; Stable' and reaffirmed 'CARE A1+' for short-term facilities, citing improved operational performance.
HBL Engineering Annual General Meeting
HBL Engineering Limited has made available the video recording of its 40th Annual General Meeting held on September 26, 2026.
HBL Engineering Annual General Meeting
HBL Engineering Ltd concluded its Annual General Meeting on September 26, 2026. Shareholders approved all nine proposed resolutions, including financial statements adoption and dividend declaration.
HBL Engineering Price Movement Clarification
HBL Engineering replied to an exchange query on a volume surge. It stated no material or undisclosed event exists and attributed the move to macro-market factors.
HBL Engineering Annual General Meeting
HBL Engineering Limited has fixed September 11, 2026, as the record date for its 40th AGM. The company recommended a 100% dividend for shareholder approval.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.